Director dealings: Haleon CFO sells shares.


Haleon revealed on Wednesday that chief financial officer Dawn Allen had disposed of 83,894 ordinary shares in the London-listed consumer healthcare company.

  • Haleon
  • 02 July 2025 15:43:43

Source: Sharecast

Allen, who made the sale in two separate transactions, offloaded the shares at an average price of 375.64p each, for a total value of £315,137.75p.

As of 1540 BST, Haleon shares were down 0.53% at 373.60p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Faron Pharmaceuticals Oy (di) (FARN)
Director name: Pätsi,Tuomo
Amount purchased: 21,500 @ 2.43
Value: 47,164.41

Triad Group (TRD)
Director name: Lander,Alison
Amount purchased: 6,722 @ 297.50p
Value: £19,997.95

Utilico Emerging Markets Ltd (di) (UEM)
Director name: Wells ,Nadya
Amount purchased: 3,290 @ 244.00p
Value: £8,027.60

Stelrad Group (SRAD)
Director name: Ker,Katherine Innes
Amount purchased: 2,515 @ 163.00p
Value: £4,099.45

Top Director Sells

Haleon (HLN)
Director name: Allen,Dawn
Amount sold: 64,329 @ 375.64p
Value: £241,644.17

Haleon (HLN)
Director name: Allen,Dawn
Amount sold: 19,565 @ 375.64p
Value: £73,493.58

Rs Group (RS1)
Director name: Ringrose ,Kate
Amount sold: 6,143 @ 580.50p
Value: £35,660.11


Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: 48.51 ( 0.55 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.